About Gero AI
Gero AI is a company based in Singapore (Singapore) founded in 2015. It operates as a AI-as-a-Service, and Professional Services. Gero AI has raised $8.2 million across 3 funding rounds from investors including VitaDAO, Melnichek Investments and Leonid Lozner. Gero AI offers products and services including Anti-Aging Therapeutics and AI Drug Discovery Platform. Gero AI operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter Singapore, Singapore
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$23.7 K (USD)-2as on Dec 31, 2022
-
Net Profit
$2.91 K (USD)-41as on Dec 31, 2022
-
EBITDA
-
Total Equity Funding
$8.2 M (USD)
in 3 rounds
-
Latest Funding Round
$6 M (USD), Series A
Oct 18, 2023
-
Investors
VitaDAO
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gero AI
Gero AI offers a comprehensive portfolio of products and services, including Anti-Aging Therapeutics and AI Drug Discovery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Therapeutics are developed to extend healthy human lifespan.
Platform is used for discovering age-related disease treatments.
Funding Insights of Gero AI
Gero AI has successfully raised a total of $8.2M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $6 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $6.0M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Series A - Gero AI | Valuation | Melnichek Investments | |
| Aug, 2020 | Amount | Series A - Gero AI | Valuation | Bulba Ventures |
|
| May, 2019 | Amount | Seed - Gero AI | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gero AI
Gero AI has secured backing from 4 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include VitaDAO, Melnichek Investments and Leonid Lozner. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment services are provided to support innovative startups.
|
Founded Year | Domain | Location | |
|
Bulba Ventures is focused on funding machine learning startups.
|
Founded Year | Domain | Location | |
|
Online platform for collective funding and advancing longevity research
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gero AI
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gero AI
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gero Ai Comparisons
Competitors of Gero AI
Gero AI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An agentic AI platform is developed for biomedical research insights.
|
|
| domain | founded_year | HQ Location |
AI-powered drug discovery platform for various diseases
|
|
| domain | founded_year | HQ Location |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| domain | founded_year | HQ Location |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| domain | founded_year | HQ Location |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| domain | founded_year | HQ Location |
AI platform used for extracting antibody data from scientific papers.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gero Ai
Frequently Asked Questions about Gero AI
When was Gero AI founded?
Gero AI was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Where is Gero AI located?
Gero AI is headquartered in Singapore, Singapore.
Is Gero AI a funded company?
Gero AI is a funded company, having raised a total of $8.2M across 3 funding rounds to date.
What is the annual revenue of Gero AI?
Annual revenue of Gero AI is $23.7K as on Dec 31, 2022.
What does Gero AI do?
Gero AI is engaged in creating therapeutics aimed at addressing the root causes of aging through physics and AI. The company operates at the intersection of theoretical physics, biology, and generative AI to develop drugs that restore resilience and delay age-related diseases. Their platform leverages over 100 million longitudinal medical records to map aging trajectories and identify causal pathways. Collaborations with pharmaceutical companies like Pfizer and Chugai are maintained to co-develop treatments for chronic age-related conditions. The mission is to double healthy human lifespan within a single generation by targeting systemic resilience loss.
Who are the top competitors of Gero AI?
Gero AI's top competitors include Owkin, Formation Bio and XtalPi.
What products or services does Gero AI offer?
Gero AI offers Anti-Aging Therapeutics and AI Drug Discovery Platform.
Who are Gero AI's investors?
Gero AI has 4 investors. Key investors include VitaDAO, Melnichek Investments, Leonid Lozner, and Bulba Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.